Biological terrorism is the intentional release of biological agents into the environment to cause disease or death in a population. The recent anthrax cases in the United States have demonstrated that bioterrorism is a real threat for civilian populations, and that emergency medicine is the first line of defense against any biological attack. Practitioners of emergency medicine need to be prepared for a bioterrorism event, equipped to identify and detect and event, as well as evaluate and treat persons who may have been exposed to biological agents. Emergency medicine practitioners should be familiar with the likely agents that might be used in a bioterrorism event.
KeywordsPublic Health Agency Rift Valley Fever Yersinia Pestis Francisella Tularensis Tickborne Encephalitis Virus
Unable to display preview. Download preview PDF.
- 1.CDC. Update: Investigation of Bioterrorism Related Anthrax and Interim Guidelines for Exposure Management and Antimicrobial TherapyGoogle Scholar
- 2.October, 2001. MMWR Weekly Report. 2001;50(42):909–919.Google Scholar
- 3.Inhalational Anthrax among Postal Workers in Washington, D.C., and New Jersey. The New York City Department of Health. Alert #5. October 25,2001.Google Scholar
- 8.CDC. Notice to Readers: Considerations for Distinguishing Influenza-Like Illness from Inhalational Anthrax. MMWR. 2001;50(44):984–986Google Scholar